Under The Rajasthan Investment Promotion Scheme, Vikas Lifecare Announces New Facility Development

Vikas Lifecare Limited has revealed its investment in a 20000 square feet fully equipped antifungal manufacturing plant located at Shahjahanpur RIICO Industrial Area under the Rajasthan Investment Promotion Scheme RIPS. The cutting-edge facility, which will be ready for commissioning in December 2024, will concentrate on the manufacture of high-grade commodity compounds like EVA, ATH, Thermoplastic Rubber, and Thermoplastic Elastomer. It highlights the company's strategy to utilize the benefits of RIPS in a manner that would create value for the company while also enhancing the industrial scope of that region.

The Rajasthan Investment Promotion Scheme has a variety of economic incentives for investors. The main attractiveness of the scheme lies in SGST refunds of 9 % on sales made and products produced in the state, employment creation incentives, and surcharge or remission on electric power charges and land revenue. Also, capital investment, as well as interest, may be granted to 115 dated firms. With a production capacity of about 5000 MTPA, the projected facility will earn about 400 - 500 million rupees per annum in revenues, significantly improving Vikas Lifecare's profitability and position in the market.
Vikas Lifecare Limited shares traded at Rupees four and thirty-four paise as of January 12, 2023. The advances were consistent with a target of one point five per cent in that session.

The stock has a now 52-week high of 8rs with a 52-week low of rupees 3.75 which means the investors are quite consistent in their interests.

Q2FY25 of the firm showed impressive net sales of Rs. 134.88 crore increased by 46.5 % compared to Rs.92.09 crore in Q2 FY24. Net profit increased to Rs. 2.15 crore which is a significant change from net loss of rs 2.91 crore sustained in the previous corresponding quarter. The same year, those who achieved annual success also progressed significantly in net profit rose to rs 13.95 crores from net losses of 15.55 crores in FY23 hence a change of 190% is commendable.

Before, Vikas Lifecare Limited had entered into a Memorandum of Understanding with the Defence Electronic Applications Lab (DEAL) Indian Institute of Technology (IIT) Delhi and the Council of Scientific and Industrial Research - National Physical Laboratory (CSIR-NPL) to catalyze the research and development of state-of-the-art graphene-based nanocomposites for Electromagnetic Interference (EMI) shielding. This collaboration regulated by an NDA is based upon developing novel designs and remedies which have universal applications in various sectoral industries.

Vikas Lifecare Limited adds to the gains as the company does not cease to be dominant in polymer and rubber compound manufacturing but also in special additives to plastics and rubbers. The company has also been certified ISO 9001:2015, additionally, their services include that of a Del-Credere agent for ONGC Petro Additions Limited and they are pursuing smart gas metering Solutions through their subsidiary Genesis Gas Solutions Pvt. Ltd.

The company has also diversified its portfolio in the field of FMCG and agro products and infrastructure development which also includes making forays into film production for the purpose of entertaining.